Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens

✍ Scribed by Naoe Goto; Hisashi Tsurumi; Hideko Goto; Yoriko Ino Shimomura; Senji Kasahara; Takeshi Hara; Ichiro Yasuda; Masahito Shimizu; Nobuo Murakami; Takeshi Yoshikawa; Kenji Fukuno; Takeshi Takahashi; Yusuke Kito; Tsuyoshi Takami; Hisataka Moriwaki

• Book ID: 113027899
• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 437 KB
• Volume: 91
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-011-1363-4